SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-23-001109
Filing Date
2023-03-23
Accepted
2023-03-23 07:33:27
Documents
1
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 zk2329427.html 4  
1 zk2329427.xml 4 12451
  Complete submission text file 0001178913-23-001109.txt   13971
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INNOVATE BIOPHARMACEUTICALS, INC. 8480 HONEYCUTT ROAD, SUITE 120 RALEIGH NC 27615
Business Address
Darvish Nissim (Reporting) CIK: 0001793602 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38807 | Film No.: 23754476